Hillsdale Investment Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-27,800
Closed -$769K 614
2021
Q4
$769K Sell
27,800
-8,000
-22% -$226K 0.05% 298
2021
Q3
$969K Sell
35,800
-2,000
-5% -$53.5K 0.07% 251
2021
Q2
$1.06M Buy
+37,800
New +$1.01M 0.08% 234
2017
Q3
Sell
-35,800
Closed -$949K 520
2017
Q2
$949K Buy
+35,800
New +$955K 0.19% 132
2016
Q2
Sell
-15,300
Closed -$400K 559
2016
Q1
$400K Buy
15,300
+2,000
+15% +$46.3K 0.14% 155
2015
Q4
$343K Buy
+13,300
New +$359K 0.13% 219
2014
Q3
Sell
-15,200
Closed -$419K 581
2014
Q2
$419K Hold
15,200
0.1% 122
2014
Q1
$445K Hold
15,200
0.12% 105
2013
Q4
$392K Buy
15,200
+500
+3% +$12.5K 0.11% 127
2013
Q3
$353K Buy
+14,700
New +$367K 0.11% 147

Other funds holding TBI

Hillsdale Investment Management's TBI Position: Q1 2022 in Review

Hillsdale Investment Management sold out of Trueblue (TBI) in Q1 2022, closing a stake of 27,800 shares — an estimated $769K sold.

Hillsdale Investment Management first reported a position in TBI in Q3 2013 and held it in 10 quarters. The position peaked at $1.06M in Q2 2021. 183 funds tracked by Wall St. Rank hold TBI as of Q1 2022.

  • Hillsdale Investment Management reported no remaining Trueblue position as of Q1 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 27,800 Trueblue shares in Q1 2022, an estimated $769K.
  • Hillsdale Investment Management first reported a position in Trueblue in Q3 2013 and held it in 10 quarters.
  • Hillsdale Investment Management's Trueblue position peaked at $1.06M in Q2 2021.
  • 183 funds tracked by Wall St. Rank held Trueblue as of Q1 2022.

Based on Hillsdale Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.